These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27059187)

  • 1. Imatinib Treatment of Lymphangiomatosis (Generalized Lymphatic Anomaly).
    Libby LJ; Narula N; Fernandes H; Gruden JF; Wolf DJ; Libby DM
    J Natl Compr Canc Netw; 2016 Apr; 14(4):383-6. PubMed ID: 27059187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel case of lymphangiomatosis in HIV.
    Spier AB; Kurtz J; Sears D
    Exp Mol Pathol; 2017 Apr; 102(2):251-254. PubMed ID: 28189546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of diffuse pulmonary lymphangiomatosis with a venous anomaly presenting with acute respiratory failure and hemoptysis.
    Nagano N; Izumi S; Katsuno T; Iikura M; Miyazaki H; Igari T; Okafuji T; Sekihara K; Nagasaka S; Hojo M
    Respir Med Case Rep; 2020; 31():101243. PubMed ID: 33088708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse abdominal lymphangiomatosis without tumoral masses: a case report.
    Belhasan D; Ghalim F
    Clin J Gastroenterol; 2024 Jun; 17(3):430-433. PubMed ID: 38460084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleuropulmonary and skeletal lymphangiomatosis with chylothorax and chylopericardium.
    Bhatti MA; Ferrante JW; Gielchinsky I; Norman JC
    Ann Thorac Surg; 1985 Oct; 40(4):398-401. PubMed ID: 4051622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Unusual Liver Tumor.
    Yang CY; Cheng KS
    Gastroenterology; 2017 Oct; 153(4):e11-e12. PubMed ID: 28881186
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report.
    Fenocchio E; Depetris I; Campanella D; Garetto L; Schianca FC; Galizia D; Grignani G; Aglietta M; Leone F
    BMC Cancer; 2016 Oct; 16(1):793. PubMed ID: 27733144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A huge necrotic liver mass in a 45-year-old woman: delayed hepatic metastasis of a gastrointestinal stromal tumor.
    Whang IY; Seo KJ; Kim HY; Kim CW; Won HS
    Korean J Intern Med; 2017 Mar; 32(2):378-379. PubMed ID: 27594421
    [No Abstract]   [Full Text] [Related]  

  • 9. Chest imaging in generalized lymphatic anomaly and kaposiform lymphangiomatosis.
    Kato H; Ozeki M; Fukao T; Matsuo M
    Pediatr Int; 2018 Jul; 60(7):667-668. PubMed ID: 29923669
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib.
    Ottmann O; Saglio G; Apperley JF; Arthur C; Bullorsky E; Charbonnier A; Dipersio JF; Kantarjian H; Khoury HJ; Kim DW; Healey D; Strauss L; Cortes JE
    Blood Cancer J; 2018 Sep; 8(9):88. PubMed ID: 30190469
    [No Abstract]   [Full Text] [Related]  

  • 11. Imatinib--A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid Leukemia in 2015.
    Gambacorti-Passerini C; Piazza R
    JAMA Oncol; 2015 May; 1(2):143-4. PubMed ID: 26181011
    [No Abstract]   [Full Text] [Related]  

  • 12. Generalized lymphatic anomalies and review of the current management landscape: a case report and review of the literature.
    Liu T; Basseri S; Mussari B; DaBreo D; SenGupta S; Villalobos D; Awad S
    J Med Case Rep; 2021 Aug; 15(1):398. PubMed ID: 34372919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib.
    Castagnetti F; Gugliotta G; Breccia M; Stagno F; Iurlo A; Albano F; Abruzzese E; Martino B; Levato L; Intermesoli T; Pregno P; Rossi G; Gherlinzoni F; Leoni P; Cavazzini F; Venturi C; Soverini S; Testoni N; Alimena G; Cavo M; Martinelli G; Pane F; Saglio G; Rosti G; Baccarani M;
    Leukemia; 2015 Sep; 29(9):1823-31. PubMed ID: 26088952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Metastatic Rectal Gastrointestinal Stromal Tumor to the Small Bowel Mesentery Treated with Neoadjuvant Imatinib and Debulking Surgery Followed by Low Anterior Resection.
    Barger J; Kurtz J; Ryan K
    Am Surg; 2017 May; 83(5):e168-170. PubMed ID: 28541845
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diffuse pulmonary lymphangiomatosis in a young adult].
    Abou Hamdan K; Chabot F; Capron F; Debelle L; Fery M; Polu JM
    Rev Mal Respir; 2001 Sep; 18(4 Pt 1):436-9. PubMed ID: 11547254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How many patients can proceed from chronic myeloid leukaemia diagnosis to deep molecular response and long-lasting imatinib discontinuation? A real life experience.
    Ferrero D; Cerrano M; Crisà E; Aguzzi C; Giai V; Boccadoro M
    Br J Haematol; 2017 Feb; 176(4):669-671. PubMed ID: 26914729
    [No Abstract]   [Full Text] [Related]  

  • 17. Emergence of del(20q) in a patient in molecular remission of chronic myelogenous leukemia during imatinib treatment, with reduction following imatinib discontinuation.
    Numata A; Kajiyama R; Itabashi M; Ishii Y; Yamamoto W; Motohashi K; Matsumoto K; Hagihara M; Ishigatsubo Y; Fujisawa S
    Leuk Lymphoma; 2016; 57(1):201-2. PubMed ID: 25860242
    [No Abstract]   [Full Text] [Related]  

  • 18. Generalized lymphangiomatosis presenting as cardiomegaly.
    Chen YL; Lee CC; Yeh ML; Lee JS; Sung TC
    J Formos Med Assoc; 2007 Mar; 106(3 Suppl):S10-4. PubMed ID: 17493902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study.
    Chiaretti S; Vitale A; Vignetti M; Piciocchi A; Fazi P; Elia L; Falini B; Ronco F; Ferrara F; De Fabritiis P; Luppi M; La Nasa G; Tedeschi A; Califano C; Fanin R; Dore F; Mandelli F; Meloni G; Foà R
    Haematologica; 2016 Dec; 101(12):1544-1552. PubMed ID: 27515250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study.
    Lee SE; Choi SY; Song HY; Kim SH; Choi MY; Park JS; Kim HJ; Kim SH; Zang DY; Oh S; Kim H; Do YR; Kwak JY; Kim JA; Kim DY; Mun YC; Lee WS; Chang MH; Park J; Kwon JH; Kim DW
    Haematologica; 2016 Jun; 101(6):717-23. PubMed ID: 26888022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.